Growth Metrics

ImmunityBio (IBRX) Free Cash Flow Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 60.84%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 88.70%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -15.72%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 66.37%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 3.98%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 137.65%
10 ImmunityBio 7.72 Bn 7.34 Bn 43.97 Mn 10.16%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 10.16%
Dec 31, 2025 11.31%
Sep 30, 2025 30.58%
Jun 30, 2025 19.76%
Mar 31, 2025 20.64%
Dec 31, 2024 34.78%
Sep 30, 2024 -3.59%
Jun 30, 2024 -38.96%
Mar 31, 2024 -4.74%
Dec 31, 2023 -35.49%
Sep 30, 2023 -23.14%
Jun 30, 2023 29.83%
Mar 31, 2023 -35.99%
Dec 31, 2022 -51.25%
Sep 30, 2022 9.04%
Jun 30, 2022 -40.68%
Mar 31, 2022 -17.39%
Dec 31, 2021 -5.67%
Sep 30, 2021 -136.62%
Jun 30, 2021 -53.42%
Mar 31, 2021 -105.68%
Dec 31, 2020 46.53%
Sep 30, 2020 -97.12%
Jun 30, 2020 -198.21%
Mar 31, 2020 -108.31%
Dec 31, 2019 -1,292.89%
Sep 30, 2019 11.62%
Jun 30, 2019 14.15%
Mar 31, 2019 25.98%
Dec 31, 2018 -3,257.02%
Sep 30, 2018 -1.84%
Jun 30, 2018 18.82%
Mar 31, 2018 -40.14%
Dec 31, 2017 102.00%
Sep 30, 2017 -51.50%
Jun 30, 2017 -146.94%
Mar 31, 2017 -46.79%
Dec 31, 2016 -1.78%
Sep 30, 2016 -158.05%
Jun 30, 2016 -222.21%
Mar 31, 2016 -33.91%
Dec 31, 2015 -355.73%
Sep 30, 2015 -470.99%
Jun 30, 2015 -41.45%
Mar 31, 2015 -19,400.00%